Lessa F.C.

Winston L.G.

McDonald L.C. Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med. 372 : 2369-2370 View in Article Scopus (400)

PubMed

Crossref

Google Scholar

Shaughnessy M.K.

Amundson W.H.

Kuskowski M.A.

et al. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol. 34 : 109-116 View in Article Scopus (39)

PubMed

Crossref

Google Scholar

Gould C.V.

Edwards J.R.

Cohen J.

et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 57 : 1304-1307 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

Longtin Y.

Trottier S.

Brochu G.

et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 56 : 67-73 View in Article Scopus (156)

PubMed

Crossref

Google Scholar

Persson S.

Jensen J.N.

Olsen K.E. Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol. 49 : 4299-4300 View in Article Scopus (51)

PubMed

Crossref

Google Scholar

Surawicz C.M.

McFarland L.V.

Greenberg R.N.

et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 31 : 1012-1017 View in Article Scopus (435)

PubMed

Crossref

Google Scholar

Weingarden A.R.

Chen C.

Bobr A.

et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 306 : G310-G319 View in Article Scopus (211)

PubMed

Crossref

Google Scholar

Mullish B, McDonald J, Kao D, et al. Understanding the mechanisms of efficacy of fecal microbiota transplantation in the treatment of Clostridium difficile infection: the potential role of bile-metabolising enzymes. Gastroenterology 2017;152(Suppl 1):S47. View in Article Google Scholar

Allegretti J.R.

Kearney S.

Li N.

et al. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 43 : 1142-1153 View in Article Scopus (64)

PubMed

Crossref

Google Scholar

Kelly C.R.

Khoruts A.

Staley C.

et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 165 : 609-616 View in Article Scopus (234)

PubMed

Crossref

Google Scholar

Youngster I.

Sauk J.

Pindar C.

et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 58 : 1515-1522 View in Article Scopus (291)

PubMed

Crossref

Google Scholar

Wang S.

Xu M.

Wang W.

et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 11 : e0161174 View in Article PubMed

Google Scholar

U.S. Food and Drug Administration. Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. Available at: https://Www.fda.gov/downloads/biologicsblood vaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/UCM488223.pdf. Accessed May 2017. View in Article Google Scholar

Lieberman A, Munoz R, Edelstein C, et al. The impact of stool banks on access to fecal microbiota transplantation for recurrent Clostridium difficile infection in the United States: a geospatial analysis. Poster presented at: American College of Gastroenterology Meeting; October 14-19, 2016; Las Vegas, NV. View in Article Google Scholar

Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. Epub 2017 Jan 13. View in Article Google Scholar

Fischer M.

Sipe B.W.

Rogers N.A.

et al. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther. 42 : 470-476 View in Article Scopus (96)

PubMed

Crossref

Google Scholar

Aroniadis O.C.

Brandt L.J.

Greenberg A.

et al. Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection: a multicenter experience. J Clin Gastroenterol. 50 : 398-402 View in Article PubMed

Google Scholar

Fischer M.

Rex D.K.

Sipe B.W. Letter: Faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection—authors' reply. Aliment Pharmacol Ther. 42 : 1031 View in Article Scopus (2)

PubMed

Crossref

Google Scholar

Fischer M, Sipe B, Cheng YW, et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach. Gut Microbes. Epub 2016 Dec 21. View in Article Google Scholar

Jackson M.

Olefson S.

Machan J.T.

et al. A high rate of alternative diagnoses in patients referred for presumed Clostridium difficile infection. J Clin Gastroenterol. 50 : 742-746 View in Article Scopus (16)

PubMed

Crossref

Google Scholar

Kelly C.R.

Ihunnah C.

Fischer M.

et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 109 : 1065-1071 View in Article Scopus (347)

PubMed

Crossref

Google Scholar

Bakken J.S.

Polgreen P.M.

Beekmann S.E.

et al. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe. 24 : 20-24 View in Article Scopus (38)

PubMed

Crossref

Google Scholar

Hamilton M.J.

Weingarden A.R.

Sadowsky M.J.

et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 107 : 761-767 View in Article Scopus (426)

PubMed

Crossref

Google Scholar

Lee C.H.

Steiner T.

Petrof E.O.

et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 315 : 142-149 View in Article Scopus (314)

PubMed

Crossref

Google Scholar

Smith M.

Kassam Z.

Burgess J.

et al. The international public stool bank: a scalable model for standardized screening and processing of donor stool for fecal microbiota transplantation. Gastroenterology. 148 ( ) View in Article Abstract

Full Text PDF

Google Scholar

Dubois N.

Ling K.

Osman M.

et al. Prospective assessment of donor eligibility for fecal microbiota transplantation at a public stool bank: Results from the evaluation of 1387 candidate donors. Open Forum Infect Dis. 2 : 962 View in Article Google Scholar

Osman M.

O’Brien K.

Stoltzner Z.

et al. Safety and efficacy of fecal microbiota transplantation for recurrent Clostridium difficile infection from an international public stool bank: results from a 2050-patient multicenter cohort. Open Forum Infect Dis. 3 : S599 View in Article Google Scholar

Hohmann E.L.

Ananthakrishnan A.N.

Deshpande V. Case records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med. 371 : 668-675 View in Article Scopus (36)

PubMed

Crossref

Google Scholar

Aas J.

Gessert C.E.

Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 36 : 580-585 View in Article Scopus (389)

PubMed

Crossref

Google Scholar

Kunde S.

Pham A.

Bonczyk S.

et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr. 56 : 597-601 View in Article Scopus (200)

PubMed

Crossref

Google Scholar

Newman K.M.

Rank K.M.

Vaughn B.P.

et al. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Gut Microbes. 8 : 303-309 View in Article Scopus (32)

PubMed

Crossref

Google Scholar

Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. Epub 2017 Feb 14. View in Article Google Scholar

Fischer M.

Kao D.

Mehta S.R.

et al. Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: a multicenter study. Am J Gastroenterol. 111 : 1024-1031 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

Obi O.

Hampton D.

Anderson T.

et al. Fecal microbiota transplant for treatment of resistant C. difficile infection using a standardized protocol: a community hospital experience. Am J Gastroenterol. 109 : S629 View in Article PubMed

Google Scholar

Zipursky J.S.

Sidorsky T.I.

Freedman C.A.

et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 55 : 1652-1658 View in Article Scopus (116)

PubMed

Crossref

Google Scholar

Lee C.H.

Belanger J.E.

Kassam Z.

et al. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis. 33 : 1425-1428 View in Article Scopus (73)

PubMed

Crossref

Google Scholar

van Beurden Y.H.

van Gils T.

van Gils N.A.

et al. Serendipity in refractory celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer. J Gastrointest Liver Dis. 25 : 385-388 View in Article PubMed

Google Scholar

Hirsch B.E.

Saraiya N.

Poeth K.

et al. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 15 ( ) View in Article Scopus (88)

PubMed

Crossref

Google Scholar

Allegretti J, Fischer M, Papa E, et al. Fecal microbiota transplantation delivered via oral capsules achieves microbial engraftment similar to traditional delivery modalities: safety, efficacy and engraftment results from a multi-center cluster randomized dose-finding study. Gastroenterology 2016;150(Suppl 1):S540. View in Article Google Scholar

Fischer M, Phelps E, Bolla R, et al. Long term risk of Clostridium difficile infection recurrence with or without antibiotics exposure following successful fecal microbiota transplant. Presented at Digestive Disease Week; May 21-24, 2016; San Diego, CA. View in Article Google Scholar